Back

Artificial intelligence enabled electrocardiogram for mortality and cardiovascular risk estimation: An actionable, explainable and biologically plausible platform

Sau, A.; Pastika, L.; Sieliwonczyk, E.; Patlatzoglou, K.; Ribeiro, A. H.; McGurk, K. A.; Zeidaabadi, B.; Zhang, H.; Macierzanka, K.; Mandic, D.; Sabino, E.; Giatti, L.; Barreto, S. M.; Camelo, L. d. V.; Tzoulaki, I.; O'Regan, D. P.; Peters, N. S.; Ware, J. S.; Ribeiro, A. L.; Kramer, D. B.; Waks, J. W.; Ng, F. S.

2024-01-15 cardiovascular medicine
10.1101/2024.01.13.24301267 medRxiv
Show abstract

Background and AimsArtificial intelligence-enhanced electrocardiograms (AI-ECG) can be used to predict risk of future disease and mortality but has not yet been adopted into clinical practice. Existing model predictions lack actionability at an individual patient level, explainability and biological plausibility. We sought to address these limitations of previous AI-ECG approaches by developing the AI-ECG risk estimator (AIRE) platform. Methods and ResultsThe AIRE platform was developed in a secondary care dataset of 1,163,401 ECGs from 189,539 patients, using deep learning with a discrete-time survival model to create a subject-specific survival curve using a single ECG. Therefore, AIRE predicts not only risk of mortality, but time-to-mortality. AIRE was validated in five diverse, transnational cohorts from the USA, Brazil and the UK, including volunteers, primary care and secondary care subjects. AIRE accurately predicts risk of all-cause mortality (C-index 0.775 (0.773-0.776)), cardiovascular (CV) death 0.832 (0.831-0.834), non-CV death (0.749 (0.747-0.751)), future ventricular arrhythmia (0.760 (0.756-0.763)), future atherosclerotic cardiovascular disease (0.696 (0.694-0.698)) and future heart failure (0.787 (0.785-0.889))). Through phenome- and genome-wide association studies, we identified candidate biological pathways for the prediction of increased risk, including changes in cardiac structure and function, and genes associated with cardiac structure, biological aging and metabolic syndrome. ConclusionAIRE is an actionable, explainable and biologically plausible AI-ECG risk estimation platform that has the potential for use worldwide across a wide range of clinical contexts for short- and long-term risk estimation. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=170 SRC="FIGDIR/small/24301267v1_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@10fedb6org.highwire.dtl.DTLVardef@bf7254org.highwire.dtl.DTLVardef@eb06edorg.highwire.dtl.DTLVardef@13ea7f_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.